Go to homepage
Go to homepage
Your Cart
US$0.00

Osteogenic Growth Peptide (90-103), ALKRQGRTLYGFGG
SP-MHCI-0759-2

Osteogenic Growth Peptide (90-103), ALKRQGRTLYGFGG

US$169.00

Excluding tax and shipping fees

Limited stock

Log in to download quote

Description

About Osteogenic Growth Peptide (90-103), ALKRQGRTLYGFGG

What is Osteogenic Growth Peptide (OGP)?

Osteogenic Growth Peptide (OGP) is a naturally occurring, 14-amino-acid peptide fragment (ALKRQGRTLYGFGG) derived from the C-terminal region of histone H4. It plays a pivotal role in bone regeneration and remodeling by stimulating the proliferation and differentiation of osteoblasts, the cells responsible for bone formation. Because of its biological activity, OGP is widely studied as a bone healing peptide in preclinical and translational research, particularly in the context of tissue engineering, orthopedic recovery, and cancer-associated bone disorders.
Research suggests that OGP modulates T-cell immunity and may influence immune responses in bone metastasis, especially in cancers such as breast cancer. The combination of regenerative and immunomodulatory properties positions Osteogenic Growth Peptide as a valuable tool in both basic research and the development of therapeutic strategie

The Human Histones H4.1 Peptide (IEDB: 419495) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Histones Peptide, H-ALKRQGRTLYGFGG-OH (Uniprot: P62805 aa: 90-103) from JPT is produced under strict quality control and quality management.

Osteogenic Growth Peptide (90-103), ALKRQGRTLYGFGG - Specifications

  • Peptide sequence: H-ALKRQGRTLYGFGG-OH
  • Amount: 1 mg
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in plastic vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Breast cancer
  • Standard Delivery Time: approx. 3 weeks

Your Custom or Scrambled Antigen Peptide!

Do you need a scrambled version of this antigen peptide?
We can produce scrambled versions for all our antigen peptides and other peptide sequences. These scrambled peptide versions are cross-checked against the Uniprot database to ensure that the scrambled sequence does not correspond to any natural sequence. Have a look at Scrambled Antigen Peptides!

Are you interested in other antigen peptides?
Choose sequence, amount and purity. We will assist you along the way: Custom Peptide Synthesis

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool and MHC Multimer for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.Why Choose JPT's OGP?JPT's Osteogenic Growth Peptide (OGP) is manufactured under stringent quality standards to ensure high purity and consistency. Each peptide batch is validated by HPLC-MS analysis, confirming its identity and structure, and delivered in a freeze-dried format for maximum stability and ease of handling.

Key Benefits:

  • Validated for immune applications, including T cell response studies
  • Free from toxic side products thanks to optimized synthesis protocols
  • Bulk and custom synthesis options available on request
  • Trusted for use in clinical studies and translational research
  • Scientific and responsive customer support

    • Researchers investigating bone healing peptides or exploring the immunological aspects of bone diseases and cancer can rely on JPT's OGP peptide for dependable results

    References

    References for Osteogenic Growth Peptide (90-103), ALKRQGRTLYGFGG

    References:
    Read References with JPT’s Antigen Peptides
    Human Histone H4.1 90-103, ALKRQGRTLYGFGG has been described in:
    Early Kinetics of the HLA Class I-Associated Peptidome of MVA.HIVconsv-Infected Cells., J Virol, 2015 (PMID: 25810538)
    Different binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoires., Immunogenetics, 2015 (PMID: 25502872)
    Immunological evaluation of individualized peptide vaccination with a low dose of estramustine for HLA-A24+ HRPC patients., Prostate, 2005 (PMID: 15378520)

    Documentation

    Documentation for Osteogenic Growth Peptide (90-103), ALKRQGRTLYGFGG


    Properties

    Properties of Osteogenic Growth Peptide (90-103), ALKRQGRTLYGFGG

    Properties Values
    Application: T-cell immunity
    Category: Antigen Peptides
    Condition / Topic: Breast cancer
    Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial
    Organism: Human
    Protein Name: Histones
    Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
    Quantification: No

    Further Information to Osteogenic Growth Peptide (90-103), ALKRQGRTLYGFGG

    Information Values
    Sequence: H-ALKRQGRTLYGFGG-OH
    Specifications: 14mer peptide as TFA salt
    Loading...

    Check our list of products, click and go.

    Get a quote